Arcellx (ACLX) had the best week in June 2022 by a mid-cap US stock the week of June 6, 2022, returning 83.7%.
| ASSET | WEEK | % RETURN |
|---|---|---|
Arcellx (ACLX) | 6/6/2022 - 6/12/2022 | 83.68% |
Cogent Biosciences (COGT) | 6/6/2022 - 6/12/2022 | 76.85% |
Belite Bio Inc ADR (BLTE) | 6/13/2022 - 6/19/2022 | 54.15% |
Akero Therapeutics (AKRO) | 6/13/2022 - 6/19/2022 | 47.39% |
Wave Life Sciences (WVE) | 6/20/2022 - 6/26/2022 | 40.3% |
Centessa Pharmaceuticals PLC ADR (CNTA) | 6/13/2022 - 6/19/2022 | 34.7% |
Miniso Group Holding (MNSO) | 6/13/2022 - 6/19/2022 | 34.09% |
Cogent Biosciences (COGT) | 6/13/2022 - 6/19/2022 | 33.19% |
Nuvalent (NUVL) | 6/20/2022 - 6/26/2022 | 32.07% |
Wave Life Sciences (WVE) | 6/6/2022 - 6/12/2022 | 31.9% |
Veracyte (VCYT) | 6/20/2022 - 6/26/2022 | 30.99% |
Appian (APPN) | 6/20/2022 - 6/26/2022 | 28.6% |
Olema Pharmaceuticals (OLMA) | 6/6/2022 - 6/12/2022 | 28.13% |
Edgewise Therapeutics (EWTX) | 6/20/2022 - 6/26/2022 | 26.93% |
10X Genomics (TXG) | 6/20/2022 - 6/26/2022 | 26.57% |
Denali Therapeutics (DNLI) | 6/20/2022 - 6/26/2022 | 26.14% |
Praxis Precision Medicines (PRAX) | 6/13/2022 - 6/19/2022 | 26.06% |
Kymera Therapeutics (KYMR) | 6/20/2022 - 6/26/2022 | 24.95% |
Immunitybio (IBRX) | 6/20/2022 - 6/26/2022 | 24.92% |
Regencell Bioscience (RGC) | 5/30/2022 - 6/5/2022 | 24.59% |
Recursion Pharmaceuticals (RXRX) | 6/13/2022 - 6/19/2022 | 23.7% |
Liquidia Technologies (LQDA) | 6/13/2022 - 6/19/2022 | 23.04% |
Terns Pharmaceuticals (TERN) | 6/20/2022 - 6/26/2022 | 22.7% |
Global-E Online (GLBE) | 6/20/2022 - 6/26/2022 | 22.48% |
Monday (MNDY) | 6/20/2022 - 6/26/2022 | 22.38% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
